Merge Labs

Merge Labs

Develops high-bandwidth brain–computer interfaces

Overview

Merge Labs develops brain–computer interfaces to connect human brains with computers. Its product focus is high-bandwidth neural implants that read neural signals and transmit data to AI systems and software, enabling bidirectional communication between brain and machine. The implants are designed to work with advances in AI and neural sensing hardware, using a system of implants, interfaces, and software to interpret brain activity and control devices or software. Compared with competitors, Merge Labs aligns with Sam Altman’s vision of human–machine convergence, leveraging OpenAI ventures connections and positioning itself as a Neuralink rival with an emphasis on higher data throughput and scalable AI-assisted interpretation. The company’s goal is to create seamless, high-bandwidth brain–computer communication that enhances human capabilities and enables new ways of interacting with technology.

Launched Recently

About Merge Labs

Simplify's Rating
Why Merge Labs is rated
C
Rated B on Competitive Edge
Rated D+ on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Robotics & Automation

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

Seed

Total Funding

$252M

Headquarters

Palo Alto, California

Founded

2025

People at Merge Labs

People at Merge Labs who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Near-term medical applications like restoring motor control position BCI as a practical AI physical interface.
  • OpenAI collaboration on scientific models accelerates neuroscience and hardware engineering progress significantly.
  • High-bandwidth neural interactions enable seamless human-AI integration to maximize human ability and agency.

What critics are saying

  • Gene therapy lacks neuron-specific targeting, risking 50-70% failure in clinical utility within 6-12 months.
  • Non-invasive ultrasound cannot decode thoughts with high fidelity due to noisy, unreliable signal transmission.
  • Circular dependency on OpenAI funding collapses if user adoption stalls within 12-18 months.

What makes Merge Labs unique

  • Merge Labs pioneers ultrasound-based non-invasive brain-computer interfaces instead of surgical electrodes.
  • It secured $252M seed funding from OpenAI, signaling strong investor confidence in non-implant neurotech.
  • The firm explores molecular neuron connections to avoid implants and boost safety for consumer use.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$252M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$252M
Merge Labs

Growth & Insights

Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

-2%

Recently Posted Jobs

Sign up to get curated job recommendations

Merge Labs is Hiring for 17 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →